Issued Patents All Time
Showing 1–25 of 33 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12390454 | Use and composition for protection against organophosphorus poisoning | — | 2025-08-19 |
| 12023315 | Pharmaceutical compositions and methods utilizing neostigmine and an NK-1 antagonist for treating myasthenia gravis | — | 2024-07-02 |
| 11896582 | Use and composition for treating myasthenia gravis and other myasthenic syndromes | — | 2024-02-13 |
| 11819485 | Levodopa fractionated dose composition and use | Thomas N. CHASE | 2023-11-21 |
| 11813247 | NK-1 antagonist compositions and methods for use in treating depression | Thomas N. CHASE | 2023-11-14 |
| 11813248 | NK-1 antagonist compositions and methods for use in treating depression | Thomas N. CHASE | 2023-11-14 |
| 11752141 | Pharmaceutical compositions and methods utilizing neostigmine and an NK-1 antagonist for treating myasthenia gravis | — | 2023-09-12 |
| 11547700 | Compositions and methods for treating synucleinopathies | Thomas N. CHASE | 2023-01-10 |
| 11439613 | Levodopa fractionated dose composition and use | Thomas N. CHASE | 2022-09-13 |
| 11439630 | Use and composition for protection against organophosphorus poisoning | — | 2022-09-13 |
| 11389420 | Pharmaceutical compositions and methods utilizing neostigmine and an NK-1 antagonist for treating myasthenia gravis | — | 2022-07-19 |
| 11318122 | Pharmaceutical combination and its use for treating synucleinopathties | Thomas N. CHASE | 2022-05-03 |
| 11266633 | NK-1 antagonist compositions and methods for use in treating depression | Thomas N. CHASE | 2022-03-08 |
| 11160809 | NK1-antagonist combination and method for treating synucleinopathies | Thomas N. CHASE | 2021-11-02 |
| 11033521 | Levodopa fractionated dose composition and use | Thomas N. CHASE | 2021-06-15 |
| 10842778 | Use and composition for treating myasthenia gravis and other myasthenic syndromes | — | 2020-11-24 |
| 10799484 | Compositions and methods for treating synucleinopathies | Thomas N. CHASE | 2020-10-13 |
| 10596139 | Oxybutynin transdermal therapeutic system muscarinic agonist combination | Thomas N. CHASE | 2020-03-24 |
| 10548855 | Memantine combinations and use | Thomas N. CHASE | 2020-02-04 |
| 10307409 | Muscarinic combinations and their use for combating hypocholinergic disorders of the central nervous system | Thomas N. CHASE | 2019-06-04 |
| 10195187 | Oxybutynin-xanomeline transdermal therapeutic system combinations | Thomas N. CHASE | 2019-02-05 |
| 10149828 | Oxybutynin transdermal therapeutic system combination | Thomas N. CHASE | 2018-12-11 |
| 9943508 | Method and composition for treating Alzheimer-type dementia | Thomas N. CHASE | 2018-04-17 |
| 9913836 | Anticholinergic neuroprotective composition and methods | Thomas N. CHASE | 2018-03-13 |
| 9896416 | Piperidinium quaternary salts | Thomas N. CHASE | 2018-02-20 |